AVR 1.04% $11.43 anteris technologies ltd

Ann: Anti-calcification Comparison Study Interim Results, page-71

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 55 Posts.
    lightbulb Created with Sketch. 16
    Hey Tiger
    Interesting if you go way back and look at when ADAPT was it was living with BioMD. (BOD) announcements state that they were in discussions with several leading heart valve manufacturers way back then. ????? So I suggest Medtronic, Edwards, Jenavalve etc already know about ADAPT and what it can and cant do. Will it give them something over and above what they already have in market or the R+D pipeline
    Also ironic that this management basically gave the all the Vaccines R+D IP to the Chinese group to keep the doors open and salaries secured, and hoped they would also back the ADAPT business.
    It would be interesting to have a Ian Fraser backed Vaccine business in the current environment.
    Look up MODERNA and their MRNA Vaccine
    This along with massive SP depreciation since WP became CEO should ring alarm bells to potential investors
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.